STEPHANIE COLE: Open Payments
NPI 1205472677 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,344 in 75 payments from 18 companies in 2025. Trend: 2023 $616 · 2024 $969 · 2025 $1,344
Food & beverage: $1,344
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 19 | $202 |
| AstraZeneca Pharmaceuticals LP | 5 | $176 |
| Gilead Sciences, Inc. | 8 | $152 |
| GlaxoSmithKline, LLC. | 6 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $99 |
| Lilly USA, LLC | 6 | $96 |
| ABBVIE INC. | 4 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Exact Sciences Corporation | 3 | $50 |
Products named: NURTEC ODT, FARXIGA, TRELEGY ELLIPTA, CAPLYTA, MOUNJARO, AIRSUPRA, Kerendia, VRAYLAR.
Industry payments across KY — which companies pay providers there.
